Forgotten Password Create Account

Opening an account enables you to complete forms on the ESSO website. To access the ESSO members area please proceed with the membership application.

Prof Cornelis Velde

Prof Cornelis Velde

Leiden University Medical CenterNetherlands


Prof. van de Velde is presently Professor of Surgical Oncology at the Leiden University Medical Center, Leiden, The Netherlands.
Cornelis  Jan Hadde van de Velde, born in The Netherlands on June 5, 1951, is married and has 2 children. He received a PhD (cum laude) in breast cancer in 1977. He received his training at the Leiden University Medical Center in Leiden and at the M.D. Anderson Hospital in Houston in surgery and surgical oncology until 1982. In 1985 he was a visiting Professor at the Seoul National University Hospital in Korea and at the National Cancer Center Hospital in Tokyo, Japan. He was made a full clinical Professor of Surgery at the Leiden University Medical Center in 1988. In 1999 he was made a Honorary Fellow of the Royal College of Surgeons (London) and Royal College of Surgeons and Physicians (Glasgow). Prof. van de Velde’s primary areas of research interests include breast, colorectal, gastric cancer and endocrine tumors. He is a Coordinator of Oncology at the Leiden University Medical Center and is a member of a number of committees there. Prof. van de Velde is also Chairman of the Dutch Royal Academy of Sciences. He founded and was the first Chairman of the Dutch Colorectal Cancer Group, the Dutch Gastric Cancer Group and the Dutch Breast Cancer Group. He was President of the European Society of Surgical Oncology from 2008 to 2010 and of the European CanCer Organisation in 2012-2013.
Prof. van de Velde was supervisor of more than 50 Ph.D. theses, coordinator of 14 projects of the Netherlands Cancer Foundation (3 present), coordinator of 6 Health Insurance Fund Projects (Liver metastases, follow up, gastric cancer surgery, gastric cancer chemotherapy, rectal cancer surgery, radiotherapy and blood transfusion), coordinator of 6 European randomized breast cancer studies and coordinator of 4 European randomized colorectal cancer studies. Translational research on minimal residual disease and biomarkers that determine prognosis, genomic and proteomic profiling of tumors is the present focus of research of his team.
Prof. van de Velde has presently authored more than 600 publications.


ESSO Industry Partners